Literature DB >> 17880531

Alteration of adhesion molecule expression and cellular polarity in hepatocellular carcinoma.

Y Cao1, H Chang, L Li, R-C Cheng, X-N Fan.   

Abstract

AIMS: To study the expression of adhesion molecules in human liver and their possible roles during hepatocarcinogenesis. METHODS AND
RESULTS: The expression of adhesion molecules in normal liver tissues, benign including probable premalignant lesions and malignant lesions was systematically investigated by immunohistochemistry and Western blotting. In normal liver, both hepatocytes and bile duct cells expressed symplekin, desmoglein 1/2, desmocollin 2, desmoplakin and plakophilin 2, but did not express desmocollin 1/3 or plakophilin 1. In benign hepatocyte lesions, expression of the adherens junctions and desmosomes was uniform and slightly increased, but symplekin appeared to show reduced expression in dysplastic lesions. In hepatocellular carcinoma (HCC), the expression of adhesion molecules was often heterogeneous and of abnormal location. Tumour cells with an abnormal distribution or loss of adhesion molecules showed an apolar arrangement of tissue architecture. The expression levels of the adhesion molecules correlated with the differentiation grades of HCC cells.
CONCLUSIONS: The decreased expression of symplekin may be an early step in the transformation of hepatocytes, whereas alteration of the expression of adherens junctions and desmosomes may indicate more serious changes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17880531     DOI: 10.1111/j.1365-2559.2007.02820.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  12 in total

Review 1.  Glycosylation and liver cancer.

Authors:  Anand Mehta; Harmin Herrera; Timothy Block
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

2.  Hepatic tight junctions: from viral entry to cancer metastasis.

Authors:  Nikki P Lee; John M Luk
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

3.  Expression and distribution of symplekin regulates the assembly and function of the epithelial tight junction.

Authors:  Hong Chang; Chen Zhang; Yi Cao
Journal:  Histochem Cell Biol       Date:  2012-01-05       Impact factor: 4.304

4.  Symplekin promotes tumorigenicity by up-regulating claudin-2 expression.

Authors:  Michael Buchert; Marina Papin; Caroline Bonnans; Charbel Darido; Warren S Raye; Véronique Garambois; André Pélegrin; Jean-François Bourgaux; Julie Pannequin; Dominique Joubert; Frédéric Hollande
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-25       Impact factor: 11.205

5.  γ-Catenin at adherens junctions: mechanism and biologic implications in hepatocellular cancer after β-catenin knockdown.

Authors:  Emily Diane Wickline; Yu Du; Donna B Stolz; Michael Kahn; Satdarshan P S Monga
Journal:  Neoplasia       Date:  2013-04       Impact factor: 5.715

6.  Loss of desmocollin-2 confers a tumorigenic phenotype to colonic epithelial cells through activation of Akt/β-catenin signaling.

Authors:  Keli Kolegraff; Porfirio Nava; My N Helms; Charles A Parkos; Asma Nusrat
Journal:  Mol Biol Cell       Date:  2011-02-16       Impact factor: 4.138

7.  Synergy analysis reveals association between insulin signaling and desmoplakin expression in palmitate treated HepG2 cells.

Authors:  Xuewei Wang; Aritro Nath; Xuerui Yang; Amanda Portis; S Patrick Walton; Christina Chan
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

8.  An open-label, single-arm, phase I/II study of lower-dose decitabine based therapy in patients with advanced hepatocellular carcinoma.

Authors:  Qian Mei; Meixia Chen; Xuechun Lu; Xiang Li; Feng Duan; Maoqiang Wang; Guangbin Luo; Weidong Han
Journal:  Oncotarget       Date:  2015-06-30

Review 9.  The Hepatic Lymphatic Vascular System: Structure, Function, Markers, and Lymphangiogenesis.

Authors:  Masatake Tanaka; Yasuko Iwakiri
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-09-14

10.  Nuclear accumulation of symplekin promotes cellular proliferation and dedifferentiation in an ERK1/2-dependent manner.

Authors:  Chen Zhang; Hai-Lei Mao; Yi Cao
Journal:  Sci Rep       Date:  2017-06-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.